NCT02502786 2025-10-07Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent OsteosarcomaMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting46 enrolled